Natera Inc’s recently made public that its PRESIDENT, CLINICALDIAGNOSTICS Moshkevich Solomon unloaded Company’s shares for reported $7.27 million on Apr 16 ’24. In the deal valued at $90.82 per share,80,000 shares were sold. As a result of this transaction, Moshkevich Solomon now holds 117,560 shares worth roughly $10.03 million.
Then, Chapman Steven Leonard sold 6,816 shares, generating $634,797 in total proceeds. Upon selling the shares at $93.13, the CEO AND PRESIDENT now owns 227,710 shares.
Before that, Sheena Jonathan sold 26,700 shares. Natera Inc shares valued at $2,468,822 were divested by the CO-FOUNDER at a price of $92.47 per share. As a result of the transaction, Sheena Jonathan now holds 321,031 shares, worth roughly $27.38 million.
A number of analysts have revised their coverage, including Raymond James’s analysts, who decreased its forecast for the stock in mid February from “a Strong buy” to “an Outperform”. BTIG Research also remained covering NTRA and reiterated its “Buy” recommendation on December 29, 2023. Guggenheim started covering the stock on December 14, 2023. It rated NTRA as “a Buy”.
Price Performance Review of NTRA
On Friday, Natera Inc [NASDAQ:NTRA] saw its stock fall -2.29% to $85.28. Over the last five days, the stock has lost -9.73%. Natera Inc shares have risen nearly 36.14% since the year began. Nevertheless, the stocks have risen 60.51% over the past one year. While a 52-week high of $98.82 was reached on 04/05/24, a 52-week low of $36.90 was recorded on 01/05/24. SMA at 50 days reached $85.61, while 200 days put it at $61.21. A total of 2.53 million shares were traded, compared to the trading of 1.17 million shares in the previous session.
Levels Of Support And Resistance For NTRA Stock
The 24-hour chart illustrates a support level at 83.21, which if violated will result in even more drops to 81.14. On the upside, there is a resistance level at 87.27. A further resistance level may holdings at 89.27. The Relative Strength Index (RSI) on the 14-day chart is 38.13, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -5.07, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 86.30%. Stochastics %K at 9.16% indicates the stock is a buying.
The most recent change occurred on December 13, 2023 when Wolfe Research began covering the stock and recommended ‘”an Outperform”‘ rating along with a $70 price target.
